BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26163512)

  • 1. The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.
    Komissarov AA; Florova G; Azghani AO; Buchanan A; Bradley WM; Schaefer C; Koenig K; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L562-72. PubMed ID: 26163512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
    Komissarov AA; Florova G; Azghani A; Karandashova S; Kurdowska AK; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L682-92. PubMed ID: 23997178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.
    Florova G; Azghani A; Karandashova S; Schaefer C; Koenig K; Stewart-Evans K; Declerck PJ; Idell S; Komissarov AA
    Am J Respir Cell Mol Biol; 2015 Apr; 52(4):429-37. PubMed ID: 25140386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
    Florova G; Azghani AO; Karandashova S; Schaefer C; Yarovoi SV; Declerck PJ; Cines DB; Idell S; Komissarov AA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L54-L68. PubMed ID: 28860148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
    Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
    Komissarov AA; Mazar AP; Koenig K; Kurdowska AK; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L568-77. PubMed ID: 19666776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.
    Karandashova S; Florova G; Azghani AO; Komissarov AA; Koenig K; Tucker TA; Allen TC; Stewart K; Tvinnereim A; Idell S
    Am J Respir Cell Mol Biol; 2013 Jan; 48(1):44-52. PubMed ID: 23002099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
    Idell S; Allen T; Chen S; Koenig K; Mazar A; Azghani A
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L25-32. PubMed ID: 16980376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision targeting of the plasminogen activator inhibitor-1 mechanism increases efficacy of fibrinolytic therapy in empyema.
    Florova G; Girard RA; Azghani AO; Sarva K; Buchanan A; Karandashova S; DeVera CJ; Morris D; Chamiso M; Koenig K; Cines DB; Idell S; Komissarov AA
    Physiol Rep; 2021 May; 9(9):e14861. PubMed ID: 33991465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.
    Idell S; Mazar A; Cines D; Kuo A; Parry G; Gawlak S; Juarez J; Koenig K; Azghani A; Hadden W; McLarty J; Miller E
    Am J Respir Crit Care Med; 2002 Oct; 166(7):920-6. PubMed ID: 12359647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.
    Strange C; Baumann MH; Sahn SA; Idell S
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):508-15. PubMed ID: 7842213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.
    Iakhiaev AV; Nalian A; Koenig K; Idell S
    Thromb Res; 2007; 120(5):715-25. PubMed ID: 17275887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema.
    Beckert L; Brockway B; Simpson G; Southcott AM; Lee YCG; Rahman N; Light RW; Shoemaker S; Gillies J; Komissarov AA; Florova G; Ochran T; Bradley W; Ndetan H; Singh KP; Sarva K; Idell S
    JCI Insight; 2019 Apr; 5(10):. PubMed ID: 30998508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-chain urokinase in empyema induced by Pasturella multocida.
    Idell S; Jun Na M; Liao H; Gazar AE; Drake W; Lane KB; Koenig K; Komissarov A; Tucker T; Light RW
    Exp Lung Res; 2009 Oct; 35(8):665-81. PubMed ID: 19895321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion.
    Abdul Hamid MF; Hasbullah AHH; Mohamad Jailaini MF; Nik Abeed NN; Ng BH; Haron H; Md Ali NA; Ismail MI; Nik Ismail NA; Abdul Rahman MR; Ban AY
    BMC Pulm Med; 2022 Nov; 22(1):439. PubMed ID: 36419155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the PAI-1 Mechanism with a Small Peptide Increases the Efficacy of Alteplase in a Rabbit Model of Chronic Empyema.
    Florova G; De Vera CJ; Emerine RL; Girard RA; Azghani AO; Sarva K; Jacob J; Morris DE; Chamiso M; Idell S; Komissarov AA
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions--analysis of predictors for failure of therapy and bleeding: a cohort study.
    Abu-Daff S; Maziak DE; Alshehab D; Threader J; Ivanovic J; Deslaurier V; Villeneuve PJ; Gilbert S; Sundaresan S; Shamji F; Lougheed C; Seely JM; Seely AJ
    BMJ Open; 2013; 3(2):. PubMed ID: 23377992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.
    Gilbert CR; Gorden JA
    Curr Opin Pulm Med; 2017 Jul; 23(4):371-375. PubMed ID: 28399008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Five-Year Study of Intrapleural Fibrinolytic Therapy in Loculated Pleural Collections.
    Barthwal MS; Marwah V; Chopra M; Garg Y; Tyagi R; Kishore K; Vijay A; Dutta V; Katoch CD; Singh S; Bhattacharya D
    Indian J Chest Dis Allied Sci; 2016; 58(1):17-20. PubMed ID: 28368566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.